OTC · SLBK
Skyline Bankshares, Inc.
$28.25$0.00 (0.0%)
Skyline Bankshares, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
Loading market information…
OTC · ATMS · USD
Stock price, earnings
Quote as of May 25, 2023, 03:53 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Artemis Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Artemis Therapeutics Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$28.25$0.00 (0.0%)
Skyline Bankshares, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
$9.93+$0.01 (+0.1%)
Southport Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 0.5% below the high.
$12.47$0.00 (0.0%)
Clover Leaf Capital Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.46% below the high.
$10.55-$11.45 (-52.05%)
Focus Impact BH3 Acquisition Co’s quoted price sits in the lower half of its reported 52-week range, 52.05% below the high.
$2.50$0.00 (0.0%)
Petrocorp Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.5% below the high.
$5.30-$0.05 (-0.93%)
James Maritime Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
$13.30+$0.05 (+0.38%)
Kingswood Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 1.48% below the high.
$6.43-$0.56 (-8.01%)
Iris Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 48.52% below the high.
